Next-generation RNA sequencing and omics techniques have displayed that most of the human genomes were transcribed into RNAs, and nearly 98% of them without coding for proteins. These 98% of RNAs are called non-coding RNAs (ncRNAs). 14 nucleotides. [15] [16] [17] The mechanisms of lncRNAs remain unclear, 18 but increasing number of in vitro and in vivo studies have shown that ln-cRNAs can be expressed in macrophage during its development and control some gene expression. [19] [20] [21] However, a systematic review uncovered the interactions among lncRNAs expressed in macrophage is not available. Hence, we reviewed recent advances in elucidation of the variability of lncRNA function within macrophages, and mainly focused on the following four aspects: biology of lncRNAs, involvement of lncRNAs in human monocyte/macrophage differentiation, characteristics of lncRNAs in macrophage polarization and dysregulation of lncRNAs in macrophage involved inflammatory diseases. Overall, this review may help to discover some potential therapeutic targets and diagnostic biomarkers for multiple diseases. 22, 23 
| B I OG ENE S IS , S TRUC TURE S AND FUN C TI ON MANNER S OF LN CRNA S
Compared with other ncRNAs, the mechanisms of lncRNAs were still unclear because of its complexity and relatively poor conservation. 24 Increased researches have already extensively enhanced the knowledge of lncRNAs, and some articles have processed stemmatic reviews on its biology, structures and function manners. For details, see Beermann, 14 Fatica 25 or Quinn. 26 Briefly, biogenesis of lncRNAs are usually transcribed by RNA Pol II(RNPII) in the nucleus, and only a fraction are more likely to be transcribed by RNPIII. 24 LncRNAs can be transcribed from intergenic (between protein-coding genes, lincRNA), intronic, natural antisense transcripts (NATs) or promoters and enhancers. 27 Bio-functional activities of lncRNAs rely on base pairing upon the primary structure, or develop by higher-order configurations on the basis of the secondary structures. 28, 29 Diversity of their structures enabled lncRNAs to perform a variety of functions. 30 LncRNAs share the same cap and polyadenylate tail structures with mRNAs, but express lower levels than mRNAs, and in generally exhibit more specific expression profiles and precise expression patterns. 31, 32 The regulation of lncRNAs is also complex and diverse. Most transcribed lncRNAs tend to remain in the cell nucleus and be assembled into chromosomes during biological processes. 31 Biological functions of most lncRNAs in accordance with previous reports can be primarily classified into 3 types 14, 33 : (a) LncRNAs act as regulator of genomic transcription in the nucleus. Transcription of certain genes are regulated by binding chromatin-modifying factors, heterogeneous nuclear ribonucleoprotein (hnRNPs) or transcription factors, with cis-or trans-acting lncRNAs and enhancer RNAs (eRNAs). Cis-regulatory way may directly silence the nearby genes of transcribed place by methylation of histone H3 and so on. 34 However, most lncRNAs work in a trans-regulatory way and play a repressor or activator role in some distant gene loci which are not even on the same chromosome. 35 LncRNAs can also originate from enhancer elements called eRNAs, acting on the regulation of enhancer activity. 36 (b) LncRNAs participate in posttranscriptional moderation in the cytoplasm. These lncRNAs can promote or weaken the translation of target mRNAs, even alter the stability of mRNAs and proteins, or change the protein translocation. 29, 33, 37, 38 Moreover, they can function as competing endogenous RNAs (ceRNAs), also called microRNA (miRNA) sponges, to protect the target mRNAs expression by directly binding to miR-NAs or keeping miRNAs away from mRNAs. 39 (c) The last function manner of lncRNAs is secreted to extracellular. It has been displayed that lncRNAs could be packed in extracellular vesicles (EVs), such as exosomes, secreted out of cell alone or bound to proteins. 40 Circulating lncRNAs show advantages in biomarkers, regulating many pathophysiological processes 41 (shown in Figure 1 ).
| LN CRNA S INVOLVE IN H UMAN MONOC Y TE/MACROPHAG E D IFFERENTIATI ON
Monocytes/macrophages originated from haematopoietic stem cells (HSCs) play a major role in non-specific immunity and inflammatory response. 42 Monocyte is a population of mononuclear leucocyte in circulating blood cells. It can transfer to diverse tissues and then differentiate into macrophage. This complex differentiation process requires a coordinated expression of transcription factors, cytokines and ncRNAs. 43 Although many of well-defined miRNAs have been recognized as key regulators involved in haematopoietic differentiation, there were few reports about lncR-NAs regulating monocyte/macrophage differentiation. 44 Chen et al have revealed that phorbol-12-myristate-13-acetate (PMA) could raise the long non-coding monocytic RNA (lnc-MC) expression in human THP-1 cell line, HL-60 cell line and CD34+ haematopoietic stem-progenitor cells (HSPCs). Mechanically, lnc-MC acted as a ceRNA to soak up miR-199a-5p and release activin A receptor type 1B (ACVR1B), 45 then enhanced the effect of haematopoiesis-specific transcription factor PU.1 on suppressing miR-199a-5p and eventually facilitated the differentiation process through activating the transforming growth factor β (TGF-β). 46 Once monocyte recruiting from bone marrow to peripheral blood, it can differentiate into macrophage with phenotypic variability. 47 LncRNA NTT was found to be expressed in resting human primary monocyte, monocyte-derived macrophage and the THP-1 cell line. resulted in cell cycle G1 arrest, differentiation into macrophages, high IL-10 and CXCL10 mRNA levels, and up-regulation of the costimulatory molecules 48 (Figure 2 and Table 1 ).
| LN CRNA s E XPRE SS I ON IN MACROPHAG E P OL ARIZ ATION AND FUN C TION

| lncRNAs expression profile in M1-like macrophage
Granulocyte macrophage colony stimulating factor (GM-CSF), LPS and Toll-like receptor (TLR) ligands always contribute to M1 polarization in macrophage. That macrophage might be polarized through the JNK pathway after binding to CCR2 and nuclear factor-κB (NF-κB), or through the activation of PI3K with increased RelA/NF-κB activity. 8 Functionally, M1-type macrophage promotes Th1 response and produces copious amounts of pro-inflammatory cytokines or reactive oxygen species (ROS) to kill pathogens. 44 TLR-triggered NF-κB is one of the best studied pathways participated in the conversion of macrophage to M1-like phenotype, 49 which is shown in Figure 3 . [50] [51] [52] [53] All TLRs, excluding TLR3, mainly activate the NF-κB-dependent or IRF7-dependent type I IFN (TLR7-9) pro-inflammatory signallings via the adapter protein myeloid differentiation marker 88 (MyD88). 54, 55 Many transcriptome sequencing analyses of macrophages stimulated with TLR ligands have shown that numerous genes and lncRNAs involved in macrophage polarization ( Figure 3 and Table 1 ), and these macrophages tended to be induced into M1 type, along with high levels of pro-inflammatory mediators. 56 FIGURE 1 Biogenesis, structures and functions of lncRNAs. EBF: enhancer-binding factors. The biogenesis of lncRNAs is mainly transcribed by RNPII in the nucleus. Bio-functional activities of lncRNAs rely on base pairing upon the primary structure, or develop by higher-order configurations on the basis of the secondary structures including helices, hairpin loops, bulges and pseudoknots. Biological functions of lncRNAs can be primarily classified into 3 types: acting as regulator of genomic transcription in the nucleus via cis-or trans-acting lncRNAs and eRNAs; participating in post-transcriptional moderation in the cytoplasm and involving in peripheral circulation. [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] LncRNAs promoted biological processes showed in green arrow, and negative regulated displayed in red line In response to TLR4 (LPS) activation, lncRNA-Nfkb2 and ln-cRNA-Rel, located near some classical pro-inflammatory transcription factors, were up-regulated and co-regulated with inflammatory response in mouse bone marrow-derived macrophages (BMDMs). 57 AS-IL1α was a NAT located in the nucleus of macrophage and expressed at a low level in resting cells. It was highly up-regulated after stimulating by TLRs via NF-ĸB signal, and then recruited RNPII to the IL-1α promoter. In the presence of abundant AS-IL1α, elevated acetylation of histone H3 at lysine 9 (H3K9) promoted the combination of RNPII and the promoter of IL-1α, but it could not control the gene's expression. 58 LncRNA cox-2 (also has been called PACER) was located at upstream of the cyclooxygenase-2 (cox-2) gene in both human and murine macrophages. PACER could directly interact with the p50/p50 homodimeric, an inhibitor of NF-κB family and subsequently resulted in activation of the cox-2 promoter. 49, 59 Moreover, lnc IL1β-eRNA and IL1β-RBT46 were found to be transcribed from enhancer regions via NF-ĸB in THP-1 cells, and predominantly localized to the nucleus, functioning as eRNAs to promote the expression of IL1-β and CXCL8. 60 After LPS stimulation, lincRNA-Tnfaip3, which is located at the tumour necrosis factor a-induced protein 3 (Tnfaip3) gene, mediated early response through NF-κB signalling in murine macrophages. LincRNA-Tnfaip3 could non-covalently unite to the high-mobility group box 1 protein (HMGB1), DNA and RNA molecules, then assembled into a complex to facilitate Hmgb1-associated histone modification and the combination of DNA and p65/ p50, eventually promoted the transcription of many inflammatory and defence genes in macrophages, 61 as well as other mice tissues induced by LPS. 62 Sirtuin-1 (SIRT1) is a conserved histone deacetylase, which can inhibit macrophage response by deacetylating H3K9 in lncRNA-CCL2 loci and transcriptionally suppressing the lncRNA-CCL2 level. 63 LncRNA-CCL2 was significantly upregulated in sepsis mice or LPS-stimulated macrophages, but the SIRT1 expression was down-regulated. 64 It could act as a ceRNA to soak up miR-199a-5p, and eventually facilitate the differentiation process through activating the transforming growth factor β (TGF-β) signalling pathway. 45, 46 In response to various stimuli, macrophages mainly polarized into two types: classical M1 and alternative M2 type, and dynamically switched its function to adapt to the specific environmental changes. LPS induced up-regulation of lncRNA Mirt2 in the cytoplasm, but the increase in Mirt2 was restricted by sustained and excessive activation of inflammatory responses at the late stage. Restoring Mirt2 expression in later stage promoted the IL-4 induced M2 polarization with a remarkable increased level of M2 markers. 53 HOTTIP expression was associated with TLR tolerance, and has been speculated to skew macrophage polarization to a "M2-like" phenotype. 82 KCNQ1OT1 could function as a miR-21a-5p decoy to up-regulate IL-10, induced polarization of macrophages into M2 type. 83, 84 LncRNA TCONS_00019715 was expressed at a higher level when M2 macrophage was converted to M1, but decreased when M1 type was converted to M2 85 
oxidase 2 (NOX2) expression and ROS production. 71 LincRNA-p21
was also found to attenuate the p65 mRNA and its translation, leading to TNF-α-stimulated NF-ĸB activity. 72 Increased lnc-IL7R was initially expressed in the nucleus and likely inhibited MyD88-dependent LPS-inducible genes expression by enhancing the trimethylation of H3K27, a mark of transcriptional silence, at its promoters. Non-Fermentable; TRAF6, TNF receptor-associated factor 6.
TA B L E 1 (Continued)
F I G U R E 3 Involvement and regulation of lncRNAs in M1-like macrophage polarization. Many toll-like receptor (TLR)-triggered polarization of M1-like macrophage mainly depends on nuclear factor-κB (NF-κB) signalling pathway. At the plasma membrane, the binding of myeloid differentiation marker 88 (MyD88) to TLRs results in the recruitment and phosphorylation of IL-1 receptor-associated kinases (IRAKs), which facilitates oligomerization (via K63) and auto-ubiquitination (via E2 ubiquitin ligase Ubc13) of TNF receptor-associated factor 6 (TRAF6). Ubiquitinated TRAF6 subsequently activates other signalling proteins, such as transforming growth factor β-activated kinase (TAK1). Then TAK1 activates the inhibitor of κB α (IκBα) kinases (IKKs), leading to degradation of IκBα and activation of NF-κB, immune and inflammatory responses. LncRNAs promote the development of M1 macrophage via NF-κB or other pathways showed in red font, whereas negative regulated displayed in blue font [50] [51] [52] [53] However, it did not seem to involve in regulating the expression of overlapped IL7R gene and viral infection. 73 Similarly, lincRNA THRIL as a negative regulation of NF-κB could interact with hnRNPL at the Tnfα gene and ensure the expression of TNF-α in dosage control, but it down-regulated in human macrophages after TLR2 activation. 74, 75 Encoded by the Tnfα loci, lncRNA SeT increased in LPS-treated murine macrophage, 76 with unstable Tnfα mRNA. 20 The above lncRNAs are important to reduce TNFα expression in macrophages. NKILA was highly expressed to restrain the NF-ĸB-driven inflammation in response to TNF-α irritant. NKILA could decorate the phosphorylation of IĸBα to inhibit its degradation and prevent NF-ĸB from being transferred to the nucleus. 77 
| Characteristics of lncRNAs in M2-like macrophage, M1/M2 switch or TMAs
Macrophage activated through an opposite manner is known as M2 type. M2 macrophage plays an essential role in adaptive response and contributes to Th2-type response involved in acute tissue damage and repair. 44, 47 However, studies on the expression of lncRNAs in M2 macrophage are still rare, and the exact mechanism of action is still unclear. Du et al found that lncRNA Mirt2 was up-regulated in the cytoplasm of macrophage after LPS stimulating, then inhibited the oligomerization and ubiquitination of TNF receptor-associated factor 6 (TRAF6) and relieved inflammatory responses at the late stage.
They speculated that Mirt2 might hide the ubiquitination sites for the E2 ubiquitin ligase Ubc13, and induce a decreased ubiquitination level of TRAF6 ( Figure 2 and Table 1 ). At the early stage, IL-4 could reduce Mirt2 via the Jak-Stat6 pathway. After restoring the expression of Mirt2, IL-4 treated macrophage was inclined to M2 polarization with a high level of M2 molecule markers. However, the elaborate mechanisms of macrophage polarization induced by Mirt2 are still unknown. 53 Murphy et al conducted real-time PCR in LPS-tolerized macrophage and found increased expression of lncRNA HAR1A and HAR1B but decreased levels of PCGEM1 and HOTTIP lncRNAs. 50 Regulating the expression of HOTTIP is associated with TLR tolerance, and has been speculated to promote macrophage into M2 phenotype. 82 In polymethyl methacrylate (PMMA)-induced BMDMs, the expression of TNF-α, iNOS and miR-21a-5p were increased, but the expression of IL-10, Arg1 and lncRNA KCNQ1OT1 were suppressed. KCNQ1OT1 might act as a miR-21a-5p decoy to up-regulate IL-10 expression, 83 and then prompt macrophages into M2 type. 84 A detailed transcriptome analysis in human macrophage revealed that lncRNA TCONS_00019715 was highly expressed when M2 type was converted to M1, but decreased when M1 type was converted to M2. Like TCONS_00019715, overexpressed P21-activated kinase 1 (PAK1) in macrophage was helpful to M1 macrophage polarization. 85 During M2 polarization, lncRNA-MM2P was increased, which was contrary to M1 macrophage. Knockdown of lncRNA-MM2P in RAW264.7 could cut down the M2 polarization by decreasing phosphorylation level of STAT6. 86 LncRNA growth-arrest-specific transcript 5 (GAS5) was up-regulated in human monocyte-derived macrophages from pneumonia children and acted as a miR-455-5p decoy to up-regulate SOCS3, then inhibited JAK2/STAT3 signalling and increased the transformation of M1 macrophage 87 ( Figure 2 and Table 1 ).
Tumour-associated macrophages (TAMs) have a particular polarization state which is deemed as M2-like macrophage. 47 Incubated in thyroid tumour microenvironment, macrophage showed an increased expression level of MALAT1, which mediated secretion of fibroblast growth factor-2 (FGF2) protein, leading to decreased cytokine release, enhanced tumour neovascularization, proliferation of thyroid cancer cells and metastatic potential. 3, 88 In TAMs isolated from thyroid cancer, expression of lncRNA nuclear enriched abundant transcript 1 (NEAT1), which is localized in the nucleus (24) , and
Arg-1 were obviously elevated, while miR-214 was significantly decreased. Indirectly, NEAT1 promoted thyroid cancer growth by inducing β-catenin expression. 89 In addition to M1, M2 type and TAMs, some macrophage subsets with unique characteristics and functions have also been reported, such as CD169+ or TCR+ macrophage. 47 However, it is still not clear about these newly discovered macrophage types, and more research is needed to prove its origin, biomarkers and differentiation processes.
Hence, we only reviewed classical M1, M2 macrophage and TAMs.
| INFL AMMATORY D IS E A S E S INDUCED BY DYS REG UL ATI ON OF LN CRNA S AND MACROPHAG E S
| Atherosclerosis and cholesterol transport
Macrophages take up oxidized low-density lipoproteins (oxLDL), causing apoptosis to form foam cells, which is the basis of atherosclerosis. 95 A transmembrane protein, the type B scavenger receptor CD36, is up-regulated on macrophage's cell membrane by oxLDL uptaking during this progress. 96 After oxLDL treatment, lncRNA MALAT1 transcription was activated through NF-κB signal.
Numerous expressed lncRNA MALAT1 promoted CD36 expression through recruiting β-catenin to the promoter region of CD36, and participated in CD36-mediated lipid uptaking. 97, 98 LncRNA MALAT1 TAMs: tumour-associated macrophages control molecule), subsequently allowed p53 binding to p300 and acted on their target genes. But in atherosclerotic plaques, expression of lincRNA-p21 was depressed. 101 LncRNA taurine up-regulated gene 1 (TUG1) was elevated in HFD-treated ApoE-/-mice, oxLDL-induced mouse macrophages and mouse VSMCs. As a target of TUG1, miR-133a was correspondingly reduced and reversed the expression of fibroblast growth factor 1 (FGF1) protein, further inhibited cell apoptosis and aggravated the foam cell formation. 102 Another increased lncRNA H19 in oxLDL-treated macrophage might facilitate effects on foam cell formation and inflammation response by reducing miR-130b. 103 Hu et al revealed that in THP-1-derived foam cells, lncRNA RP5-833A20.1 (NFIA-A1) was increased but the transcription factor nuclear factor 1A (NFIA) was decreased. Besides, induced high miR-382-5p level might diminish the NFIA mRNA and protein. 104 Further reports elucidated that NFIA could promote retrograde cholesterol transport (RCT), reduce the circulating levels of pro-inflammatory cytokines and significantly improve plasma hyperlipidaemia. 105 Transmembrane protein ATP-binding cassette transporter A1 (ABCA1) takes part in the process of RCT. Human high-density lipoprotein (HDL) deficiencies, such as syndrome sterol deposits and premature atherosclerosis, are caused by ABCA1 mutations. 106 In THP-1 derived foam cells, lincRNA-DYNLRB2-2 was distinctly increased, which promoted ABCA1-mediated RCT and inhibited inflammation response by up-regulating G-protein-coupled receptor (GPR119), and eventually slowed the atherosclerotic plaque formation down. 107 LncRNAs E330013P06 (E33) is one of the visibly increased lncR-NAs in macrophages under T2DM conditions. Compared with db/+ mice, pro-inflammatory genes were overexpressed from db/db mice, which indicated that diabetes inhibited M2 phenotypic transformation and promoted the inflammatory response of M1 macrophage.
Additionally, expression of E33 in macrophages greatly increased the CD36 level, and further supported the foam cell formation and proatherogenic responses of macrophages. 114 A new study indicated that, under high glucose conditions or diabetic wounds, lncRNA
Lethe was decreased in macrophages, and released more free p65-NF-κB to the nucleus, which promoted ROS and NOX2 production, eventually impaired wound healing. 115 
| Coeliac disease
Coeliac disease (CeD) is a immune-mediated primary intestinal malabsorption syndrome caused by gluten intolerance, and the pathological feature is small intestinal mucosal lesions. 116 
| Mycobacterial infections
Macrophages can phagocytose invading mycobacterium tuberculosis (Mtb), so it is considered as the main residence for Mtb and gives the ability to escape damage. LncRNAs have proved to involve in anti-mycobacterial infection, but their effects on this response remain unelucidated. 119 An arrayed analysis of lncRNAs was con- 
Another microarray analysis conducted in human macrophages with
H37Ra or H37Rv about 72 hours, revealed that lncRNAs diversity expressed in macrophages. In particular, up-regulated MIR3945HG V1 and MIR3945HG V2 showed potential diagnostic markers for Mtb infection, but their functions were still unknown. 121 
| Other relevant diseases
Silicosis is one of the most severe occupational diseases, and shows common histological changes in persistent inflammation and pulmonary fibrosis. Studies have indicated that silica particles could promote the liberation of copious oxidants and inflammatory factors in macrophages and epithelial cells, which caused a deposition in extracellular matrix, and finally led to pulmonary fibrosis. 122 Silica-induced pulmonary fibrosis, macrophages exposed to silica or fibroblasts exposed to TGF-β were decreased the miR-489 level. 123 However, the effects of circRNAs in macrophage differentiation and polarization have not to be widely explored. Whether circRNA involved in the activation of macrophages and whether it affect the development of macrophages by regulating lncRNAs require more further experiments to detect. 126 Unfortunately, there is a defect in our paper that many studies on the mechanisms of lncRNAs expressed in macrophages have not been studied intensively. It is expected that more exploration about lncRNAs in regulating innate immune response and macrophage-associated biological processes will be carried out. In conclusion, lncRNAs harmonizes in the development and function of macrophages, which can prevent the human body from being damaged by internal and external stimuli without generating an excessive immune response. Increased or depressed lncR-NAs in macrophages might be regarded as potential therapeutic targets and diagnostic biomarkers, and provided a new sight into the treatment of inflammatory diseases and cancers. 
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